BOLD-100 MoA Research to Be Presented at the AACR Annual Meeting ...Middle East

PHILADELPHIA, April 9, 2021 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, a first-in-class anti-cancer agent, announced that Sandra Van Schaeybroeck, PhD (Queen's University Belfast) will be presenting research supporting BOLD-100 as a...

Hence then, the article about bold 100 moa research to be presented at the aacr annual meeting was published today ( Friday 09/04/2021 - 03:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BOLD-100 MoA Research to Be Presented at the AACR Annual Meeting )

Also on site :

• Mozilla President: meet the open source ‘rebel alliance’ that could break Big Tech’s grip on AI
• Comcast Stock Pops on NBCUniversal Spin-Off as Wall Street Waves Farewell to Vertical Integration
• Supreme Court allows states to count mail-in ballots that arrive late, rejecting RNC challenge